Crossmark

Using digital health to facilitate compliance with standardized pediatric cancer treatment guidelines in Tanzania: protocol for an early-stage effectiveness-implementation hybrid study

Crossref DOI link: https://doi.org/10.1186/s12885-020-6611-3

Published Online: 2020-03-29

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vasudevan, Lavanya https://orcid.org/0000-0003-2900-6070
Schroeder, Kristin

Raveendran, Yadurshini

Goel, Kunal

Makarushka, Christina

Masalu, Nestory

Zullig, Leah L.
Funding

Funding for this research was provided by:

National Center for Advancing Translational Sciences (1KL2TR002554)

National Cancer Institute (R21CA217268)
License Information

Text and Data Mining valid from 2020-03-29

Version of Record valid from 2020-03-29
More Information

Article History

Received: 7 November 2019

Accepted: 7 February 2020

First Online: 29 March 2020

Ethics approval and consent to participate

: The study protocol is approved by institutional review boards in the United States of America (Duke University Health System, Pro00094010) and Tanzania (Catholic University Health and Allied Services (CUHAS), CREC/292/2018; Lake Zone branch of the National Institute for Medical Research, MR/53/100/566; and the National Health Research Ethics Review Sub-Committee (NatHREC), NIMR/HQ/R.8a/Vol.IX/3096). Changes to the protocol will be communicated via protocol amendment by the study principal investigators. Documentation of informed consent will be obtained from all participants over the age of 18. Patients under the age of 18 will provide assent, while documentation of informed consent will be obtained from their parents or legal guardians.. For historical patients, the institutional review boards have approved a waiver of consent.

: Written consent for publication will be obtained from study participants.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below